K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer
1998

K-ras Mutation in Lung Cancer

Sample size: 64 publication Evidence: moderate

Author Information

Author(s): M Sagawa, Y Saito, S Fujimura, RI Linnoila

Primary Institution: National Cancer Institute

Hypothesis

The K-ras mutation occurs in the early stage of carcinogenesis in lung cancer.

Conclusion

The study found that K-ras mutations are present in early preneoplastic lesions and are homogeneous in lung carcinoma tissues.

Supporting Evidence

  • 14 out of 61 samples had a mutation in the K-ras codon 12.
  • 12 out of 41 adenocarcinomas had a mutation.
  • All carcinoma tissues examined had the K-ras mutation.

Takeaway

Scientists looked at lung cancer samples and found a common mutation that happens early in the disease, which helps us understand how lung cancer starts.

Methodology

The study used selective ultraviolet radiation fractionation and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to analyze lung carcinoma tissues.

Limitations

The study had a limited number of preneoplastic lesions and did not detect mutations in all types of lesions.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication